Review Article
Esser C, Rannug A, Stockinger B. The aryl hydrocarbon receptor in immunity. Trends Immunol. 2009;30(9):447-454.
10.1016/j.it.2009.06.005Gutiérrez-Vázquez C, Quintana FJ. Regulation of the immune response by the aryl hydrocarbon receptor. Immunity. 2018;48(1):19-33.
10.1016/j.immuni.2017.12.012Wright EJ, De Castro KP, Joshi AD, Elferink CJ. Canonical and non-canonical aryl hydrocarbon receptor signaling pathways. Curr Opin Toxicol. 2017;2:87-92.
10.1016/j.cotox.2017.01.001Zelante T, Iannitti RG, Cunha C, De Luca A, Giovannini G, Pieraccini G, et al. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity. 2013;39(2):372-385.
10.1016/j.immuni.2013.08.003Funatake CJ, Marshall NB, Steppan LB, Mourich DV, Kerkvliet NI. Cutting edge: activation of the aryl hydrocarbon receptor by 2,3,7,8-tetrachlorodibenzo-p-dioxin generates a population of CD4+CD25+ cells with characteristics of regulatory T cells. J Immunol. 2005;175(7):4184-4188.
10.4049/jimmunol.175.7.4184Huang W, Rui K, Wang X, Peng N, Zhou W, Shi X, et al. The aryl hydrocarbon receptor in immune regulation and autoimmune pathogenesis. J Autoimmun. 2023;138:103049.
10.1016/j.jaut.2023.103049Coretti L, Buommino E, Lembo F. The aryl hydrocarbon receptor pathway: a linking bridge between the gut microbiome and neurodegenerative diseases. Front Cell Neurosci. 2024;18:1433747.
10.3389/fncel.2024.1433747Hou JJ, Ma AH, Qin YH. Activation of the aryl hydrocarbon receptor in inflammatory bowel disease: insights from gut microbiota. Front Cell Infect Microbiol. 2023;13:1279172.
10.3389/fcimb.2023.1279172Denison MS, Nagy SR. Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu Rev Pharmacol Toxicol. 2003;43:309-334.
10.1146/annurev.pharmtox.43.100901.135828Beamer CA, Shepherd DM. Role of the aryl hydrocarbon receptor (AhR) in lung inflammation. Semin Immunopathol. 2013;35(6):693-704.
10.1007/s00281-013-0391-7Vogel CFA, Van Winkle LS, Esser C, Haarmann-Stemmann T. The aryl hydrocarbon receptor as a target of environmental stressors – Implications for pollution mediated stress and inflammatory responses. Redox Biol. 2020;34:101530.
10.1016/j.redox.2020.101530Mezrich JD, Fechner JH, Zhang X, Johnson BP, Burlingham WJ, Bradfield CA. An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells. J Immunol. 2010;185(6):3190-3198.
10.4049/jimmunol.0903670Rannug A, Rannug U. The tryptophan derivative 6-formylindolo[3,2-b]carbazole, FICZ, a dynamic mediator of endogenous aryl hydrocarbon receptor signaling, balances cell growth and differentiation. Crit Rev Toxicol. 2018;48(7):555-574.
10.1080/10408444.2018.1493086De Juan A, Segura E. Modulation of immune responses by nutritional ligands of aryl hydrocarbon receptor. Front. Immunol. 2021;12:645168.
10.3389/fimmu.2021.645168Wang M, Guo J, Hart AL, Li JV. Indole-3-aldehyde reduces inflammatory responses and restores intestinal epithelial barrier function partially via aryl hydrocarbon receptor (AhR) in experimental colitis models. J Inflamm Res. 2023;16:5845-5864.
10.2147/JIR.S432747Su X, Gao Y, Yang R. Gut microbiota-derived tryptophan metabolites maintain gut and systemic homeostasis. Cells. 2022;11(15):2296.
10.3390/cells11152296Piwowarski JP, Kiss AK, Granica S, Moeslinger T. Urolithins, gut microbiota-derived metabolites of ellagitannins, inhibit LPS-induced inflammation in RAW264.7 murine macrophages. Mol Nutr Food Res. 2015;59(11):2168-2177.
10.1002/mnfr.201500264Marinelli L, Martin-Gallausiaux C, Bourhis JM, Béguet-Crespel F, Blottière HM, Lapaque N, et al. Identification of the novel role of butyrate as AhR ligand in human intestinal epithelial cells. Sci Rep. 2019;9(1):643.
10.1038/s41598-018-37019-2Cannon AS, Nagarkatti PS, Nagarkatti M. Targeting AhR as a novel therapeutic modality against inflammatory diseases. Int J Mol Sci. 2021;23(1):288.
10.3390/ijms23010288Mohammadi-Bardbori A, Bengtsson J, Rannug U, Rannug A, Wincent E. Quercetin, resveratrol, and curcumin are indirect activators of the aryl hydrocarbon receptor (AhR). Chem Res Toxicol. 2012;25(9):1878-1884.
10.1021/tx300169eZhao B, Degroot DE, Hayashi A, He G, Denison MS. CH223191 is a ligand-selective antagonist of the Ah (Dioxin) receptor. Toxicol Sci. 2010;117(2):393-403.
10.1093/toxsci/kfq217Coelho NR, Tomkiewicz C, Correia MJ, Gonçalves-Dias C, Barouki R, Pereira SA, et al. First evidence of aryl hydrocarbon receptor as a druggable target in hypertension induced by chronic intermittent hypoxia. Pharmacol Res. 2020;159:104869.
10.1016/j.phrs.2020.104869Smith KJ, Murray IA, Tanos R, Tellew J, Boitano AE, Bisson WH, et al. Identification of a high-affinity ligand that exhibits complete aryl hydrocarbon receptor antagonism. J Pharmacol Exp Ther. 2011;338(1):318-327.
10.1124/jpet.110.178392Ciolino HP, Yeh GC. The flavonoid galangin is an inhibitor of CYP1A1 activity and an agonist/antagonist of the aryl hydrocarbon receptor. Br J Cancer. 1999;79(9-10):1340-1346.
10.1038/sj.bjc.6690216Lamas B, Natividad JM, Sokol H. Aryl hydrocarbon receptor and intestinal immunity. Mucosal Immunol. 2018;11(4):1024-1038.
10.1038/s41385-018-0019-2Sondermann NC, Faßbender S, Hartung F, Hätälä AM, Rolfes KM, Vogel CFA, et al. Functions of the aryl hydrocarbon receptor (AhR) beyond the canonical AhR/ARNT signaling pathway. Biochem Pharmacol. 2023;208:115371.
10.1016/j.bcp.2022.115371Ishihara Y, Kado SY, Bein KJ, He Y, Pouraryan AA, Urban A, et al. Aryl hydrocarbon receptor signaling synergizes with TLR/NF-κB-signaling for induction of IL-22 through canonical and non-canonical AhR pathways. Front Toxicol. 2022;3:787360.
10.3389/ftox.2021.787360Denison MS, Faber SC. And now for something completely different: diversity in ligand-dependent activation of Ah receptor responses. Curr Opin Toxicol. 2017;2:124-131.
10.1016/j.cotox.2017.01.006Seok SH, Ma ZX, Feltenberger JB, Chen H, Chen H, Scarlett C, et al. Trace derivatives of kynurenine potently activate the aryl hydrocarbon receptor (AhR). J Biol Chem. 2018;293(6):1994-2005.
10.1074/jbc.RA117.000631Evans BR, Karchner SI, Allan LL, Pollenz RS, Tanguay RL, Jenny MJ, et al. Repression of aryl hydrocarbon receptor (AhR) signaling by AhR repressor: role of DNA binding and competition for AhR nuclear translocator. Mol Pharmacol. 2008;73(2):387-398.
10.1124/mol.107.040204Vogel CFA, Haarmann-Stemmann T. The aryl hydrocarbon receptor repressor - More than a simple feedback inhibitor of AhR signaling: Clues for its role in inflammation and cancer. Curr Opin Toxicol. 2017;2:109-119.
10.1016/j.cotox.2017.02.004Xiong R, Shao D, Do S, Chan WK. Activation of chaperone-mediated autophagy inhibits the aryl hydrocarbon receptor function by degrading this receptor in human lung epithelial carcinoma A549 cells. Int J Mol Sci. 2023;24(20):15116.
10.3390/ijms242015116Fernández-Gallego N, Sánchez-Madrid F, Cibrian D. Role of AhR ligands in skin homeostasis and cutaneous inflammation. Cells. 2021;10(11):3176.
10.3390/cells10113176Stockinger B, Veldhoen M, Hirota K. Modulation of Th17 development and function by activation of the aryl hydrocarbon receptor-the role of endogenous ligands. Eur J Immunol. 2009;39(3):652-654.
10.1002/eji.200839134Yasuda T, Takagi T, Asaeda K, Hashimoto H, Kajiwara M, Azuma Y, et al. Urolithin A-mediated augmentation of intestinal barrier function through elevated secretory mucin synthesis. Sci Rep. 2024;14(1):15706.
10.1038/s41598-024-65791-xHo PP, Steinman L. The aryl hydrocarbon receptor: a regulator of Th17 and Treg cell development in disease. Cell Res. 2008;18(6):605-608.
10.1038/cr.2008.63Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006;441(7090):235-238.
10.1038/nature04753Quintana FJ, Basso AS, Iglesias AH, Korn T, Farez MF, Bettelli E, et al. Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature. 2008;453(7191):65-71.
10.1038/nature06880Rehman A, Koh Y-S. Impact of ambient particulate matter on the skin’s immune system. J Bacteriol Virol 2022;52(3):83-93.
10.4167/jbv.2022.52.3.083Arooj M, Rehman A, Hyun CL, Rafique A, Kang H-K, Hyun JW et al. Diesel exhaust particulate matter impairs toll-like receptor signaling and host defense against staphylococcal cutaneous infection in mice. Ecotoxicol Environ Saf. 2023;249:114443.
10.1016/j.ecoenv.2022.114443Ehrlich AK, Pennington JM, Bisson WH, Kolluri SK, Kerkvliet NI. TCDD, FICZ, and other high affinity AhR ligands dose-dependently determine the fate of CD4+ T cell differentiation. Toxicol Sci. 2018;161(2):310-320.
10.1093/toxsci/kfx215van Voorhis M, Knopp S, Julliard W, Fechner JH, Zhang X, Schauer JJ, et al. Exposure to atmospheric particulate matter enhances Th17 polarization through the aryl hydrocarbon receptor. PLoS One. 2013;8(12):e82545.
10.1371/journal.pone.0082545Matthews NC, Pfeffer PE, Mann EH, Kelly FJ, Corrigan CJ, Hawrylowicz CM, et al. Urban particulate matter-activated human dendritic cells induce the expansion of potent inflammatory Th1, Th2, and Th17 effector cells. Am J Respir Cell Mol Biol. 2016;54(2):250-262.
10.1165/rcmb.2015-0084OCCastan͂eda AR, Pinkerton KE, Bein KJ, Magan͂a-Méndez A, Yang HT, Vogel CFA, et al. Ambient particulate matter activates the aryl hydrocarbon receptor in dendritic cells and enhances Th17 polarization. Toxicol Lett. 2018;292:85-96.
10.1016/j.toxlet.2018.04.020Matthews NC, Faith A, Pfeffer P, Lu H, Kelly FJ, Hawrylowicz CM, et al. Urban particulate matter suppresses priming of T helper type 1 cells by granulocyte/macrophage colony-stimulating factor-activated human dendritic cells. Am J Respir Cell Mol Biol. 2014;50(2):281-291.
10.1165/rcmb.2012-0465OCO’Driscoll CA, Gallo ME, Hoffmann EJ, Fechner JH, Schauer JJ, Bradfield CA, et al. Polycyclic aromatic hydrocarbons (PAHs) present in ambient urban dust drive proinflammatory T cell and dendritic cell responses via the aryl hydrocarbon receptor (AhR) in vitro. PLoS One. 2018;13(12):e0209690.
10.1371/journal.pone.0209690- Publisher :The Korean Society for Microbiology and The Korean Society of Virology
- Publisher(Ko) :대한미생물학회‧대한바이러스학회
- Journal Title :JOURNAL OF BACTERIOLOGY AND VIROLOGY
- Volume : 55
- No :4
- Pages :298-309
- Received Date : 2025-08-17
- Revised Date : 2025-09-15
- Accepted Date : 2025-11-07
- DOI :https://doi.org/10.4167/jbv.2025.55.4.298


JOURNAL OF BACTERIOLOGY AND VIROLOGY









